Direct evidence for concurrent morphological and genetic heterogeneity in an invasive ductal carcinoma of triple-negative phenotype

Journal of Clinical Pathology

Volumn 64, Issue 9, 2011, Pages 822-828

  Patani, Neill ^a   Barbashina, Violetta ^a   Lambros, Maryou B K ^a   Gauthier, Arnaud ^a   Mansour, Marthe ^a   Mackay, Alan ^a   Reis Filho, Jorge S ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOCRINE CARCINOMA; ARTICLE; CELL DIFFERENTIATION; CHROMOSOME 9P; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CHROMOSOME MICRODISSECTION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENETIC GAIN; GENETICS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MORPHOLOGICAL TRAIT; PHENOTYPE; PRIORITY JOURNAL; TISSUE MICROARRAY; TRIPLE NEGATIVE BREAST CANCER; VALIDATION PROCESS;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL;

EID: 80051888840     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2011-200135     Document Type: Article

References (16)

1. Foulkes W.D., Smith I.E., Reis-Filho J.S. Triple-negative breast cancer. N Engl J Med 2010;363:1938-1948
2. Weigelt B., Reis-Filho J.S. Histological and molecular types of breast cancer: Is there a unifying taxonomy? Nat Rev Clin Oncol 2009;6:718-730
3. Tavassoli F.A., Devilee P. World Health Organization Classification of Tumours. Pathology and genetics of tumours of the breast and female genital organs. IARC Press, Lyon, 2003.
4. Eusebi V., Millis R.R., Cattani M.G., et al. Apocrine carcinoma of the breast. A morphologic and immunocytochemical study. Am J Pathol 1986;123:532-541 (Pubitemid 16090148)
5. Visvader J.E. Cells of origin in cancer. Nature 2011;469:314-322
6. Ashworth A., Lord C.J., Reis-Filho J.S. Genetic interactions in cancer progression and treatment. Cell 2011;145:30-38
7. Marusyk A., Polyak K. Tumor heterogeneity: causes and consequences. Biochim Biophys Acta 2010;1805:105-17.
8. Shackleton M., Quintana E., Fearon E.R., et al. Heterogeneity in cancer: Cancer stem cells versus clonal evolution. Cell 2009;138:822-829
9. Geyer F.C., Weigelt B., Natrajan R., et al. Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas. J Pathol 2010;220:562-573
10. Tan D.S., Lambros M.B., Natrajan R., et al. Getting it right: Designing microarray (and not 'microawry') comparative genomic hybridization studies for cancer research. Lab Invest 2007;87:737-754 (Pubitemid 47077258)
11. Reis-Filho J.S., Drury S., Lambros M.B., et al. ESR1 gene amplification in breast cancer: A common phenomenon? Nat Genet 2008;40:809-810; author reply 10-12.
12. Polyak K., Weinberg R.A. Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nat Rev Cancer 2009;9:265-273
13. Anderson K., Lutz C., Van Delft F.W., et al. Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature 2011;469:356-361
14. Mullighan C.G., Phillips L.A., Su X., et al. Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science 2008;322:1377-1380 (Pubitemid 352775249)
15. Ding L., Ellis M.J., Li S., et al. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 2010;464:999-1005.
16. Jones C., Damiani S., Wells D., et al. Molecular cytogenetic comparison of apocrine hyperplasia and apocrine carcinoma of the breast. Am J Pathol 2001;158:207-214 (Pubitemid 32096486)